Since HER2 positivity is inversely correlated with hormone receptor expression in breast carcinoma, this may have interfered with getting an even stronger correlation between the hormone receptor status and tubule formation or lobular differentiation. The gene discussed is ERBB2; the disease is breast carcinoma.